716 related articles for article (PubMed ID: 21827486)
21. PHEA-graft-polybutylmethacrylate copolymer microparticles for delivery of hydrophobic drugs.
Licciardi M; Di Stefano M; Craparo EF; Amato G; Fontana G; Cavallaro G; Giammona G
Int J Pharm; 2012 Aug; 433(1-2):16-24. PubMed ID: 22575755
[TBL] [Abstract][Full Text] [Related]
22. Viscosity of polymer solution phase and other factors controlling the dissolution of theophylline microspheres prepared by the emulsion solvent evaporation method.
Obeidat WM; Price JC
J Microencapsul; 2003; 20(1):57-65. PubMed ID: 12519702
[TBL] [Abstract][Full Text] [Related]
23. Fabrication and in vivo evaluation of highly pH-responsive acrylic microparticles for targeted gastrointestinal delivery.
Kendall RA; Alhnan MA; Nilkumhang S; Murdan S; Basit AW
Eur J Pharm Sci; 2009 Jun; 37(3-4):284-90. PubMed ID: 19491017
[TBL] [Abstract][Full Text] [Related]
24. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
Kranz H; Bodmeier R
Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
[TBL] [Abstract][Full Text] [Related]
25. Microencapsulation of antimicrobial ceftiofur drugs.
Bodmeier R; Chen H; Davidson RG; Hardee GE
Pharm Dev Technol; 1997 Nov; 2(4):323-34. PubMed ID: 9552461
[TBL] [Abstract][Full Text] [Related]
26. Encapsulation of water-soluble drugs by an o/o/o-solvent extraction microencapsulation method.
Elkharraz K; Ahmed AR; Dashevsky A; Bodmeier R
Int J Pharm; 2011 May; 409(1-2):89-95. PubMed ID: 21356287
[TBL] [Abstract][Full Text] [Related]
27. Preparation of preformed porous PLGA microparticles and antisense oligonucleotides loading.
Ahmed AR; Bodmeier R
Eur J Pharm Biopharm; 2009 Feb; 71(2):264-70. PubMed ID: 18840521
[TBL] [Abstract][Full Text] [Related]
28. Cationic Eudragit® polymers as excipients for microparticles prepared by solvent evaporation method.
Vysloužil J; Bavoľárová J; Kejdušová M; Vetchý D; Dvořáčková K
Ceska Slov Farm; 2013 Dec; 62(6):249-54. PubMed ID: 24393112
[TBL] [Abstract][Full Text] [Related]
29. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.
Jelvehgari M; Atapour F; Nokhodchi A
Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883
[TBL] [Abstract][Full Text] [Related]
30. Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method.
Uchida T; Yagi A; Oda Y; Goto S
J Microencapsul; 1996; 13(5):509-18. PubMed ID: 8864988
[TBL] [Abstract][Full Text] [Related]
31. Preparation and evaluation of Eudragit S 100 microspheres as pH-sensitive release preparations for piroxicam and theophylline using the emulsion-solvent evaporation method.
Obeidat WM; Price JC
J Microencapsul; 2006 Mar; 23(2):195-202. PubMed ID: 16754375
[TBL] [Abstract][Full Text] [Related]
32. Microencapsulation of cytarabine using poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers as surfactant agents.
Diab R; Hamoudeh M; Boyron O; Elaissari A; Fessi H
Drug Dev Ind Pharm; 2010 Apr; 36(4):456-69. PubMed ID: 19877831
[TBL] [Abstract][Full Text] [Related]
33. One-step fabrication of triple-layered polymeric microparticles with layer localization of drugs as a novel drug-delivery system.
Lee WL; Widjaja E; Loo SC
Small; 2010 May; 6(9):1003-11. PubMed ID: 20358528
[TBL] [Abstract][Full Text] [Related]
34. Nano and microparticle engineering of water insoluble drugs using a novel spray-drying process.
Schafroth N; Arpagaus C; Jadhav UY; Makne S; Douroumis D
Colloids Surf B Biointerfaces; 2012 Feb; 90():8-15. PubMed ID: 22019455
[TBL] [Abstract][Full Text] [Related]
35. Novel preparation techniques for alginate-poloxamer microparticles controlling protein release on mucosal surfaces.
Moebus K; Siepmann J; Bodmeier R
Eur J Pharm Sci; 2012 Feb; 45(3):358-66. PubMed ID: 22178531
[TBL] [Abstract][Full Text] [Related]
36. Process and formulation variables in the preparation of wax microparticles by a melt dispersion technique. I. Oil-in-water technique for water-insoluble drugs.
Bodmeier R; Wang J; Bhagwatwar H
J Microencapsul; 1992; 9(1):89-98. PubMed ID: 1613647
[TBL] [Abstract][Full Text] [Related]
37. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.
Krishnamachari Y; Madan P; Lin S
Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982
[TBL] [Abstract][Full Text] [Related]
38. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
[TBL] [Abstract][Full Text] [Related]
39. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
40. Encapsulation of poorly soluble basic drugs into enteric microparticles: a novel approach to enhance their oral bioavailability.
Alhnan MA; Murdan S; Basit AW
Int J Pharm; 2011 Sep; 416(1):55-60. PubMed ID: 21679756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
